What is the recommended target resting heart rate and titration strategy for beta‑blocker therapy in adults?

Target Resting Heart Rate and Beta-Blocker Titration in Adults

For adults on beta-blocker therapy, titrate the dose to achieve a resting heart rate of less than 60-65 bpm (or <70 bpm in some contexts), prioritizing this heart rate target over achieving a specific drug dose, as heart rate control—not the absolute dose—drives clinical benefit.

Context-Specific Recommendations

Heart Failure with Reduced Ejection Fraction (HFrEF)

Target Heart Rate:

• Primary target: <60-65 bpm for symptomatic patients 1, 2, 1
• Alternative lenient target: <110 bpm initially, with stricter control if symptoms persist 3

Titration Strategy:

1. Start low and go slow:

   • Bisoprolol: Start 1.25 mg once daily → Target 10 mg once daily
   • Carvedilol: Start 3.125 mg twice daily → Target 25-50 mg twice daily
   • Metoprolol succinate CR/XL: Start 12.5-25 mg once daily → Target 200 mg once daily 4

2. Double the dose at minimum 2-week intervals 4

3. Monitor at each titration:

   • Heart rate, blood pressure
   • Clinical status (symptoms, signs of congestion, body weight)
   • Blood chemistry at 1-2 weeks after initiation and final dose 4

4. Aim for at least 50% of target dose as a minimum acceptable threshold 5

Critical Insight: The evidence strongly supports that heart rate reduction drives mortality benefit more than achieving a specific dose 6, 7, 8, 9. Studies show patients achieving HR <70 bpm have better outcomes regardless of beta-blocker dose, while those on target doses but with HR ≥70 bpm have worse outcomes 7, 8.

Hypertrophic Cardiomyopathy (HCM)

Target Heart Rate: <60-65 bpm 1, 2, 1

• If low doses are ineffective for controlling angina or dyspnea, titrate specifically to achieve resting HR <60-65 bpm
• Use up to generally accepted maximum doses to achieve this target
• Use with caution in patients with sinus bradycardia or severe conduction disease 1, 2, 1

Tachycardia-Induced Cardiomyopathy

Target Heart Rate: <80 bpm 10

• Beta-blockers are preferred first-line agents
• Consider amiodarone, digoxin, or rate-limiting calcium channel blockers if beta-blockers don't achieve target 10

Problem-Solving During Titration

If heart rate drops <50 bpm with worsening symptoms:

• Halve the beta-blocker dose
• If severe deterioration, stop beta-blocker (rarely necessary)
• Review need for other heart rate-slowing drugs (digoxin, calcium channel blockers) 4

If worsening heart failure symptoms develop:

• Double diuretic dose first
• If ineffective, halve beta-blocker dose
• Review in 1-2 weeks; seek specialist advice if no improvement 4

Temporary symptomatic deterioration occurs in 20-30% of patients during up-titration—this is expected and usually manageable with medication adjustment 4

Real-World Performance Gap

Despite clear guidelines, 43% of heart failure patients fail to achieve target heart rate control even months post-hospitalization 11. Additionally, 61% of follow-up time is spent with HR ≥70 bpm in real-world cohorts 9. This represents a major opportunity for improved outcomes through better titration practices.

Key Principle

Heart rate control is the mechanism of benefit, not the drug dose itself. When forced to choose between achieving target dose versus target heart rate, prioritize heart rate control 6, 7, 12, 8. The mantra "some beta-blocker is better than no beta-blocker" applies 4, but achieving HR <65-70 bpm provides the greatest mortality and morbidity reduction.